SCA
AGN

STALEY CAPITAL ADVISERS’s Allergan Inc AGN Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,400
Closed -$248K – 167
2020
Q1 		$248K Hold
1,400
– – 0.02% 126
2019
Q4 		$268K Hold
1,400
– – 0.02% 151
2019
Q3 		$236K Hold
1,400
– – 0.02% 151
2019
Q2 		$234K Hold
1,400
– – 0.02% 155
2019
Q1 		$205K Buy
+1,400
New +$205K 0.02% 158
2018
Q4 		– Sell
-1,400
Closed -$267K – 182
2018
Q3 		$267K Hold
1,400
– – 0.02% 139
2018
Q2 		$233K Buy
+1,400
New +$233K 0.02% 147

STALEY CAPITAL ADVISERS's AGN Position: Q2 2020 in Review

STALEY CAPITAL ADVISERS sold out of Allergan Inc (AGN) in Q2 2020, closing a stake of 1,400 shares — an estimated $248K sold.

STALEY CAPITAL ADVISERS first reported a position in AGN in Q2 2018 and held it in 7 quarters. The position peaked at $268K in Q4 2019. 0 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • STALEY CAPITAL ADVISERS reported no remaining Allergan Inc position as of Q2 2020 after selling out during the quarter.
  • STALEY CAPITAL ADVISERS sold 1,400 Allergan Inc shares in Q2 2020, an estimated $248K.
  • STALEY CAPITAL ADVISERS first reported a position in Allergan Inc in Q2 2018 and held it in 7 quarters.
  • STALEY CAPITAL ADVISERS's Allergan Inc position peaked at $268K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2020.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q2 2020, filed 7 Aug 2020.